Skip Nav Destination
Issues
1 September 2009
-
Cover Image
Cover Image
Immunohistochemical analysis of cyclin D1b, a variant of cyclin D1, in human prostate adenocarcinoma. Images were acquired using the Automated Quantitative Analysis (AQUA) Platform (HistoRx). Adenocarcinomas were co-stained for cyclin D1b (red), epithelial cytokeratin (green), and DAPI to show nuclei (blue). For further details, please see Comstock and coworkers on page 5338 in this issue. - PDF Icon PDF LinkTable of Contents
ISSN 1078-0432
EISSN 1557-3265
CCR Translations
Molecular Pathways
Review
Perspective
Human Cancer Biology
The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
Martin A. Cheever; James P. Allison; Andrea S. Ferris; Olivera J. Finn; Benjamin M. Hastings; Toby T. Hecht; Ira Mellman; Sheila A. Prindiville; Jaye L. Viner; Louis M. Weiner; Lynn M. Matrisian
Cyclin D1 Splice Variants: Polymorphism, Risk, and Isoform-Specific Regulation in Prostate Cancer
Clay E.S. Comstock; Michael A. Augello; Ruth Pe Benito; Jason Karch; Thai H. Tran; Fransiscus E. Utama; Elizabeth A. Tindall; Ying Wang; Craig J. Burd; Eric M. Groh; Hoa N. Hoang; Graham G. Giles; Gianluca Severi; Vanessa M. Hayes; Brian E. Henderson; Loic Le Marchand; Laurence N. Kolonel; Christopher A. Haiman; Raffaele Baffa; Leonard G. Gomella; Erik S. Knudsen; Hallgeir Rui; Susan M. Henshall; Robert L. Sutherland; Karen E. Knudsen
Immunohistochemical Expression of Estrogen and Progesterone Receptors Identifies a Subset of NSCLCs and Correlates with EGFR Mutation
Maria G. Raso; Carmen Behrens; Matthew H. Herynk; Suyu Liu; Ludmila Prudkin; Natalie C. Ozburn; Denise M. Woods; Ximing Tang; Reza J. Mehran; Cesar Moran; J. Jack Lee; Ignacio I. Wistuba
Gene Expression Profiling of Bone Marrow Endothelial Cells in Patients with Multiple Myeloma
Roberto Ria; Katia Todoerti; Simona Berardi; Addolorata Maria Luce Coluccia; Annunziata De Luisi; Michela Mattioli; Domenica Ronchetti; Fortunato Morabito; Attilio Guarini; Maria Teresa Petrucci; Franco Dammacco; Domenico Ribatti; Antonino Neri; Angelo Vacca
Cancer Therapy: Preclinical
mTOR Is a Promising Therapeutic Target Both in Cisplatin-Sensitive and Cisplatin-Resistant Clear Cell Carcinoma of the Ovary
Seiji Mabuchi; Chiaki Kawase; Deborah A. Altomare; Kenichirou Morishige; Kenjiro Sawada; Masami Hayashi; Masahiko Tsujimoto; Mareo Yamoto; Andres J. Klein-Szanto; Russell J. Schilder; Masahide Ohmichi; Joseph R. Testa; Tadashi Kimura
Humanized Anti-Interleukin-6 Receptor Antibody Suppresses Tumor Angiogenesis and In vivo Growth of Human Oral Squamous Cell Carcinoma
Satoru Shinriki; Hirofumi Jono; Kazutoshi Ota; Mitsuharu Ueda; Mareina Kudo; Tomoko Ota; Yuichi Oike; Motoyoshi Endo; Mutsuko Ibusuki; Akimitsu Hiraki; Hideki Nakayama; Yoshihiro Yoshitake; Masanori Shinohara; Yukio Ando
Insulin-Like Growth Factor-1 Receptor Inhibition Induces a Resistance Mechanism via the Epidermal Growth Factor Receptor/HER3/AKT Signaling Pathway: Rational Basis for Cotargeting Insulin-Like Growth Factor-1 Receptor and Epidermal Growth Factor Receptor in Hepatocellular Carcinoma
Christèle Desbois-Mouthon; Aurore Baron; Marie-José Blivet-Van Eggelpoël; Laetitia Fartoux; Corinne Venot; Friedhelm Bladt; Chantal Housset; Olivier Rosmorduc
Differences in Repair of DNA Cross-links between Lymphocytes and Epithelial Tumor Cells from Colon Cancer Patients Measured In vitro with the Comet Assay
Mercedes Herrera; Gemma Dominguez; Jose M. Garcia; Cristina Peña; Carmen Jimenez; Javier Silva; Vanesa Garcia; Irene Gomez; Raquel Diaz; Paloma Martin; Felix Bonilla
Imaging, Diagnosis, Prognosis
The Importance of Protein Kinase A in Prostate Cancer: Relationship to Patient Outcome in Radiation Therapy Oncology Group Trial 92-02
Alan Pollack; Kyounghwa Bae; Li-Yan Khor; Tahseen Al-Saleem; M. Elizabeth Hammond; Varagur Venkatesan; Roger W. Byhardt; Sucha O. Asbell; William U. Shipley; Howard M. Sandler
A New Immunostain Algorithm Classifies Diffuse Large B-Cell Lymphoma into Molecular Subtypes with High Accuracy
William W.L. Choi; Dennis D. Weisenburger; Timothy C. Greiner; Miguel A. Piris; Alison H. Banham; Jan Delabie; Rita M. Braziel; Huimin Geng; Javeed Iqbal; Georg Lenz; Julie M. Vose; Christine P. Hans; Kai Fu; Lynette M. Smith; Min Li; Zhongfeng Liu; Randy D. Gascoyne; Andreas Rosenwald; German Ott; Lisa M. Rimsza; Elias Campo; Elaine S. Jaffe; David L. Jaye; Louis M. Staudt; Wing C. Chan
[11C]Choline Positron Emission Tomography in Estrogen Receptor–Positive Breast Cancer
Kaiyumars B. Contractor; Laura M. Kenny; Justin Stebbing; Adil Al-Nahhas; Carlo Palmieri; Dudley Sinnett; Jacqueline S. Lewis; Katy Hogben; Safiye Osman; Sami Shousha; Charles Lowdell; R. Charles Coombes; Eric O. Aboagye
Imaging Mass Spectrometry of a Specific Fragment of Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Kinase Kinase 2 Discriminates Cancer from Uninvolved Prostate Tissue
Lisa H. Cazares; Dean Troyer; Savvas Mendrinos; Raymond A. Lance; Julius O. Nyalwidhe; Hind A. Beydoun; Mary Ann Clements; Richard R. Drake; O. John Semmes
A Phase I Study of a 2-Day Lapatinib Chemosensitization Pulse Preceding Nanoparticle Albumin-Bound Paclitaxel for Advanced Solid Malignancies
Amy J. Chien; Julie A. Illi; Andrew H. Ko; Wolfgang M. Korn; Lawrence Fong; Lee-may Chen; Mohammed Kashani-Sabet; Charles J. Ryan; Jonathan E. Rosenberg; Sarita Dubey; Eric J. Small; Thierry M. Jahan; Nola M. Hylton; Benjamin M. Yeh; Yong Huang; Kevin M. Koch; Mark M. Moasser
Cancer Therapy: Clinical
Mapatumumab, a Fully Human Agonistic Monoclonal Antibody That Targets TRAIL-R1, in Combination with Gemcitabine and Cisplatin: a Phase I Study
Constantijne H. Mom; Jaap Verweij; Corina N.A.M. Oldenhuis; Jourik A. Gietema; Norma Lynn Fox; Renée Miceli; Ferry A.L.M. Eskens; Walter J. Loos; Elisabeth G.E. de Vries; Stefan Sleijfer
A Randomized, Double-Blind, Placebo-Controlled, Phase II Study Comparing the Tolerability and Efficacy of Ipilimumab Administered with or without Prophylactic Budesonide in Patients with Unresectable Stage III or IV Melanoma
Jeffrey Weber; John A. Thompson; Omid Hamid; David Minor; Asim Amin; Ilan Ron; Ruggero Ridolfi; Hazem Assi; Anthony Maraveyas; David Berman; Jonathan Siegel; Steven J. O'Day
Letter to the Editor
Corrections
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.
RSS Feeds